The potential benefits and risks of the use of dual antiplatelet therapy beyond 6months following sirolimus-eluting stent implantation for low-risk patients-Reference-Cited by-同舟云学术

The potential benefits and risks of the use of dual antiplatelet therapy beyond 6months following sirolimus-eluting stent implantation for low-risk patients

Published:2011-05 Issue:3 Volume:57 Page:283-289
ISSN:0914-5087
Container-title:Journal of Cardiology
language:en
Short-container-title:Journal of Cardiology

Author:

Nakagawa Takafumi,Hiasa Yoshikazu,Hosokawa Shinobu,Minami Tomoko,Yano Yudai,Yoneda Kohei,Mizobe Michiko,Murakami Naotsugu,Tobetto Yohei,Chen Hirotoshi,Miyazaki Shinichiro,Mahara Keitaro,Ogura Riyo,Miyajima Hitoshi,Yuba Kenichiro,Takahashi Takefumi,Kishi Koichi,Ohtani Ryuji

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference15 articles.

1. 2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of American Heart Association Task Force on practice guidelines;King;Circulation,2008

2. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized control trial;Steinhubl;JAMA,2002

3. Effect of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study;Mehta;Lancet,2001

4. Triple antiplatelet therapy reduces ischemic events after drug-eluting stent implantation: drug-eluting stenting followed by cilostazol treatment reduces adverse serious cardiac events (DECREASE registry);Lee;Am Heart J,2010

5. Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38)

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of in vitro endothelialized drug‐eluting stent using human peripheral blood‐derived endothelial progenitor cells;Journal of Tissue Engineering and Regenerative Medicine;2020-07-27

2. Long-Term Efficacy and Safety of Everolimus-Eluting Stent Implantation in Japanese Patients with Acute Coronary Syndrome: Five-Year Real-World Data from the Tokyo-MD PCI Study;Journal of Interventional Cardiology;2019-11-03

3. Stent thrombosis and platelet reactivity;Cor et Vasa;2013-04-01

4. The prevalence of malignant neoplastic and non-malignant gastrointestinal lesions in cardiology inpatients;Journal of Cardiology;2013-02

5. Prognostic impact of using drug-eluting-stents on outcome and strategy in multivessel PCI: Data from the Frankfurt MV-PCI registry;Journal of Cardiology;2013-01